ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)

SIMPLE SUMMARY: The assessment of risk of recurrence following surgery in patients with localized colorectal cancer (CRC) is crucial to indicate systemic adjuvant therapy. The presence of circulating tumor (ct)DNA in the plasma of patients after treatment with curative intent has recently been defin...

Descripción completa

Detalles Bibliográficos
Autores principales: Masfarré, Laura, Vidal, Joana, Fernández-Rodríguez, Concepción, Montagut, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226638/
https://www.ncbi.nlm.nih.gov/pubmed/34201274
http://dx.doi.org/10.3390/cancers13122869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226638/
https://www.ncbi.nlm.nih.gov/pubmed/34201274
http://dx.doi.org/10.3390/cancers13122869

Ejemplares similares